Geode Capital Management, LLC Neuro Sense Therapeutics Ltd. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 15,870 shares of NRSN stock, worth $30,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,870
Previous 15,870
-0.0%
Holding current value
$30,629
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NRSN
# of Institutions
12Shares Held
195KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY50.5KShares$97,4660.0% of portfolio
-
Meitav Dash Investments LTD40KShares$77,2000.0% of portfolio
-
Xtx Topco LTD London, X033.7KShares$65,0520.0% of portfolio
-
Commonwealth Equity Services, LLC17.3KShares$33,2920.0% of portfolio
-
Two Sigma Securities, LLC New York, NY14.7KShares$28,3800.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $22.5M